KPMG names Carole Streicher head of Deal Advisory and Strategy
KPMG US has appointed Carole Streicher, a Chicago-based partner, as leader of the deal advisory and strategy (DAS) practice.
In the role, Streicher will oversee a cross-functional team of 2,300 professionals who help clients buy, sell, and restructure globally, as well as optimize value.
Streicher joined KPMG in 1996 after completing a bachelor’s degree in accounting at Butler University. During her 25-year career at the Big Four firm, Streicher has advised corporate, private equity, and public organizations on all aspects of the M&A transaction lifecycle, from deal strategy to diligence to post-close value creation. She has advised on cross-border deals across North America, Europe, Asia, and Latin America.
Streicher previously served as leader of the US healthcare and life sciences deal advisory and strategy practice.
An active member of the KPMG Network of Women, Streicher has also worked to help build a more diverse, equitable, and inclusive firm.
“I am honored to serve as the new leader of DAS and look forward to leading our team of partners and professionals to value for our clients," Streicher said. "The M&A market is exceptionally robust right now offering our people a dynamic environment to build a career. As the new leader of the practice, I am excited to introduce my new senior leadership team, half of whom are from under-represented groups, which showcases KPMG's continued commitment to fostering diversity, equity, and inclusion."
Continuing its rally from the second half of 2020, global M&A deal value rose to a record $1.3 trillion in Q1 2021 – a 94% year-over-year increase, according to data from Refinitiv. The pandemic’s fallout and the growing recovery have been driving deal activity, as companies and investors with capital pursue opportunities.
Sellers grew as many businesses fell into distress, while others pursued strategies to part with non-core assets while valuations were high. Companies who saw their business models upended by Covid-19, meanwhile, have made plays for companies in adjacent sectors to spur transformation.
